BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10515534)

  • 1. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival.
    Theuer CP; Nastanski F; Brewster WR; Butler JA; Anton-Culver H
    Am Surg; 1999 Oct; 65(10):915-21. PubMed ID: 10515534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.
    Gill S; Shah A; Le N; Cook EF; Yoshida EM
    J Clin Oncol; 2003 Jun; 21(11):2070-6. PubMed ID: 12775731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
    Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
    Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
    Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
    ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology.
    Lee JH; Choi IJ; Kook MC; Nam BH; Kim YW; Ryu KW
    Br J Surg; 2010 May; 97(5):732-6. PubMed ID: 20235088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
    Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced gastric carcinoma with signet ring cell histology.
    Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
    Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
    Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
    Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil.
    Fanelli MF; de Paiva TF; Silva MJ; Benevides CF; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Mello CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC; Chinen LT
    J Surg Oncol; 2009 Nov; 100(6):452-5. PubMed ID: 19697363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases.
    Hass HG; Smith U; Jäger C; Schäffer M; Wellhäuber U; Hehr T; Markmann HU; Nehls O; Denzlinger C
    Onkologie; 2011; 34(12):682-6. PubMed ID: 22156447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked elevation of plasma carcinoembryonic antigen and stomach carcinoma.
    Horie Y; Miura K; Matsui K; Yukimasa A; Ohi S; Hamamoto T; Kawasaki H
    Cancer; 1996 May; 77(10):1991-7. PubMed ID: 8640661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.
    Yendamuri S; Huang M; Malhotra U; Warren GW; Bogner PN; Nwogu CE; Groman A; Demmy TL
    Cancer; 2013 Sep; 119(17):3156-61. PubMed ID: 23719932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study.
    Jiang CG; Wang ZN; Sun Z; Liu FN; Yu M; Xu HM
    J Surg Oncol; 2011 Jun; 103(7):700-3. PubMed ID: 21308685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of gastric cancer patients with bone marrow metastases.
    Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
    Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Signet ring cancer of the stomach: clinico-morphological features, postsurgical results and prognosis].
    Nered SN; Klimenkov AA; Smilidi IS; Perevoshchikov AG; Delektorskaia VV
    Vopr Onkol; 2006; 52(3):294-300. PubMed ID: 17191701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.